Association between Body Mass Index and Gastric Cancer Risk According to Effect Modification by Helicobacter pylori Infection

Purpose Few studies investigated roles of body mass index (BMI) on gastric cancer (GC) risk according to Helicobacter pylori infection status. This study was conducted to evaluate associations between BMI and GC risk with consideration of H. pylori infection information. Materials and Methods We performed a case-cohort study (n=2,458) that consists of a subcohort, (n=2,193 including 67 GC incident cases) randomly selected from the Korean Multicenter Cancer Cohort (KMCC) and 265 incident GC cases outside of the subcohort. H. pylori infection was assessed using an immunoblot assay. GC risk according to BMI was evaluated by calculating hazard ratios (HRs) and their 95% confidence intervals (95% CIs) using weighted Cox hazard regression model. Results Increased GC risk in lower BMI group (< 23 kg/m2) with marginal significance, (HR, 1.32; 95% CI, 0.98 to 1.77) compared to the reference group (BMI of 23-24.9 kg/m2) was observed. In the H. pylori non-infection, both lower (< 23 kg/m2) and higher BMI (≥ 25 kg/m2) showed non-significantly increased GC risk (HR, 10.82; 95% CI, 1.25 to 93.60 and HR, 11.33; 95% CI, 1.13 to 113.66, respectively). However, these U-shaped associations between BMI and GC risk were not observed in the group who had ever been infected by H. pylori. Conclusion This study suggests the U-shaped associations between BMI and GC risk, especially in subjects who had never been infected by H. pylori.

[1]  M. McBurney,et al.  Risk of Deficiency in Multiple Concurrent Micronutrients in Children and Adults in the United States , 2017, Nutrients.

[2]  C. Abnet,et al.  Body mass index and risk of gastric cancer: A 30‐year follow‐up study in the Linxian general population trial cohort , 2017, Cancer science.

[3]  K. Jung,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014 , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  J. Ferlay,et al.  Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration , 2015, International journal of cancer.

[5]  J. Ferlay,et al.  Global patterns of cardia and non-cardia gastric cancer incidence in 2012 , 2015, Gut.

[6]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[7]  Dazhi Xu,et al.  Vitamin Intake Reduce the Risk of Gastric Cancer: Meta-Analysis and Systematic Review of Randomized and Observational Studies , 2014, PloS one.

[8]  K. Bhaskaran,et al.  Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults , 2014, The Lancet.

[9]  P. Enck,et al.  Review article: associations between Helicobacter pylori and obesity ‐ an ecological study , 2014, Alimentary pharmacology & therapeutics.

[10]  Xiaolin Wang,et al.  Body Mass Index and Risk of Gastric Cancer: A Meta-analysis of a Population with More Than Ten Million from 24 Prospective Studies , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[11]  C. Mathers,et al.  Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.

[12]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[13]  Y. Yamaoka Mechanisms of disease: Helicobacter pylori virulence factors , 2010, Nature Reviews Gastroenterology &Hepatology.

[14]  Isabel Azevedo,et al.  Chronic Inflammation in Obesity and the Metabolic Syndrome , 2010, Mediators of inflammation.

[15]  H. El‐Serag,et al.  The epidemiology of obesity. , 2010, Gastroenterology clinics of North America.

[16]  E. El-Omar,et al.  Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. , 2008, Journal of medical microbiology.

[17]  J. Fraumeni,et al.  A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. , 2008, European journal of cancer.

[18]  D. Corley,et al.  Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas , 2008, Cancer Epidemiology Biomarkers & Prevention.

[19]  R. Goldbohm,et al.  Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study , 2007, Gut.

[20]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[21]  D. Graham,et al.  New Serological Assay for Detection of Putative Helicobacter pylori Virulence Factors , 2002, Journal of Clinical Microbiology.

[22]  D. Forman,et al.  Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry , 2001, Cancer Causes & Control.

[23]  A. Martí,et al.  Obesity and immune function relationships , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[24]  W E Barlow,et al.  Analysis of case-cohort designs. , 1999, Journal of clinical epidemiology.

[25]  R. Sutton,et al.  New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology , 1999, British Journal of Cancer.

[26]  D. Kang,et al.  Korean Multi-center Cancer Cohort Study including a Biological Materials Bank (KMCC-I). , 2002, Asian Pacific journal of cancer prevention : APJCP.